                         SEQUENCE LISTING

<110>  aratinga.bio TNP
 
<120>  DMSO-Free Synthesis of Oligopeptide-Modified Poly(Beta-Amino 
       Ester)s and Their Use in Nanoparticle Delivery Systems

<130>  12269-0602

<140>  PCT/IB2020/000783
<141>  2020-09-21

<150>  62/903,799
<151>  2019-09-21

<160>  55    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  1

Cys His His His 
1               


<210>  2
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  2

Cys His His His His 
1               5   


<210>  3
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  3

Cys His His His His His 
1               5       


<210>  4
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  4

Cys Arg Arg Arg 
1               


<210>  5
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  5

Cys Arg Arg Arg Arg 
1               5   


<210>  6
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  6

Cys Arg Arg Arg Arg Arg 
1               5       


<210>  7
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  7

Cys Lys Lys Lys 
1               


<210>  8
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  8

Cys Lys Lys Lys Lys 
1               5   


<210>  9
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  9

Cys Lys Lys Lys Lys Lys 
1               5       


<210>  10
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  10

Cys Glu Glu Glu 
1               


<210>  11
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  11

Cys Glu Glu Glu Glu 
1               5   


<210>  12
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  12

Cys Glu Glu Glu Glu Glu 
1               5       


<210>  13
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  13

Cys Asp Asp Asp 
1               


<210>  14
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  14

Cys Asp Asp Asp Asp 
1               5   


<210>  15
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  15

Cys Asp Asp Asp Asp Asp 
1               5       


<210>  16
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  16

Cys His Arg His 
1               


<210>  17
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  17

Cys His Arg Arg 
1               


<210>  18
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  18

Cys His Lys His 
1               


<210>  19
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  19

Cys His Lys Lys 
1               


<210>  20
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  20

Cys His Glu His 
1               


<210>  21
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  21

Cys His Glu Glu 
1               


<210>  22
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  22

Cys His Asp His 
1               


<210>  23
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  23

Cys His Asp Asp 
1               


<210>  24
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  24

Cys Arg His Arg 
1               


<210>  25
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  25

Cys Arg His His 
1               


<210>  26
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  26

Cys Arg Lys Arg 
1               


<210>  27
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  27

Cys Arg Lys Lys 
1               


<210>  28
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  28

Cys Arg Glu Arg 
1               


<210>  29
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  29

Cys Arg Glu Glu 
1               


<210>  30
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  30

Cys Arg Asp Arg 
1               


<210>  31
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  31

Cys Arg Asp Asp 
1               


<210>  32
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  32

Cys Lys His Lys 
1               


<210>  33
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  33

Cys Lys His His 
1               


<210>  34
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  34

Cys Lys Arg Lys 
1               


<210>  35
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  35

Cys Lys Arg Arg 
1               


<210>  36
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  36

Cys Asp His Asp 
1               


<210>  37
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  37

Cys Asp His His 
1               


<210>  38
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  38

Cys Asp Arg Asp 
1               


<210>  39
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  39

Cys Asp Arg Arg 
1               


<210>  40
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  40

Cys Asp Lys Asp 
1               


<210>  41
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  41

Cys Asp Lys Lys 
1               


<210>  42
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  42

Cys Glu His Glu 
1               


<210>  43
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  43

Cys Glu His His 
1               


<210>  44
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  44

Cys Glu Arg Glu 
1               


<210>  45
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  45

Cys Glu Arg Arg 
1               


<210>  46
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  46

Cys Glu Asp Glu 
1               


<210>  47
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  PBAE-modifying oligopeptide

<400>  47

Cys Glu Asp Asp 
1               


<210>  48
<211>  12
<212>  PRT
<213>  Human immunodeficiency virus

<400>  48

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Gln 
1               5                   10          


<210>  49
<211>  18
<212>  PRT
<213>  Drosophila melanogaster

<400>  49

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Gly Gly 
        


<210>  50
<211>  13
<212>  PRT
<213>  Simian virus 40

<400>  50

Cys Gly Tyr Gly Pro Lys Lys Lys Arg Lys Val Gly Gly 
1               5                   10              


<210>  51
<211>  21
<212>  PRT
<213>  Vespula lewisii

<400>  51

Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu 
            20      


<210>  52
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Cell penetrating peptide

<400>  52

Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Arg Val 
            20      


<210>  53
<211>  18
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Multiple antigenic peptide

<400>  53

Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210>  54
<211>  15
<212>  PRT
<213>  Feline leukemia virus

<400>  54

Arg Arg Arg Arg Asn Arg Thr Arg Arg Asn Arg Arg Arg Val Arg 
1               5                   10                  15  


<210>  55
<211>  18
<212>  PRT
<213>  Mus musculus

<400>  55

Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


